These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells. Kalland T; Belfrage H; Bhiladvala P; Hedlund G J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566 [TBL] [Abstract][Full Text] [Related]
64. Psychoneuroimmunology and Natural Killer Cells: The Chromium-Release Whole-Blood Assay. Fletcher MA; Barnes Z; Broderick G; Klimas NG Methods Mol Biol; 2018; 1781():209-220. PubMed ID: 29705850 [TBL] [Abstract][Full Text] [Related]
65. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event. Steele TA; Brahmi Z J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683 [TBL] [Abstract][Full Text] [Related]
66. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines. Wright SC; Bonavida B J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292 [TBL] [Abstract][Full Text] [Related]
67. Measuring natural killer cell cytotoxicity by flow cytometry. Wong WY; Wong H; Cheung SP; Chan E Pathology; 2019 Apr; 51(3):286-291. PubMed ID: 30803738 [TBL] [Abstract][Full Text] [Related]
68. Two unique human leukemic T-cell lines endowed with a stable cytotoxic function and a different spectrum of target reactivity analysis and modulation of their lytic mechanisms. Cesano A; Santoli D In Vitro Cell Dev Biol; 1992; 28A(9-10):648-56. PubMed ID: 1429367 [TBL] [Abstract][Full Text] [Related]
69. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells. Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930 [TBL] [Abstract][Full Text] [Related]
70. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line. Sato T; Okubo M; Wada Y; Sato N; Kikuchi K Jpn J Cancer Res; 1989 Jul; 80(7):655-61. PubMed ID: 2507488 [TBL] [Abstract][Full Text] [Related]
72. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
73. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility. Uchida A; Vánky F; Klein E J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505 [TBL] [Abstract][Full Text] [Related]
74. A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry. Goldberg JE; Sherwood SW; Clayberger C J Immunol Methods; 1999 Apr; 224(1-2):1-9. PubMed ID: 10357200 [TBL] [Abstract][Full Text] [Related]
75. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389 [TBL] [Abstract][Full Text] [Related]
76. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]
77. Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays. Williams BA; Wang XH; Keating A Cytotherapy; 2010 Nov; 12(7):951-60. PubMed ID: 20230219 [TBL] [Abstract][Full Text] [Related]